Sun Life Financial Inc. · SLF · FY2026 Q2 · Calendar Q3 2026

Sun Life posts strong Q2 EPS growth as risks remain in dental and asset management

Sun Life's Q2 results support a constructive operating picture: earnings growth, Asia and U.S. momentum, asset-management flows, and strong capital were offset by identifiable execution and margin risks. The balance of evidence favors monitoring whether these growth drivers persist while dental restructuring and fee pressure are contained.

Reported After market closeNYSEFinancial Services $45.03B market cap
100quality score

Earnings scorecard

Reported versus consensus
Reported EPS $1.46 Consensus $1.39
EPS surprise +5.0% Reported versus consensus
Reported revenue $956.0M Consensus $994.3M
Revenue surprise -3.9% Reported versus consensus

Market reaction

event-close to next-session close
Stock move -0.5% Event window
SPY move +0.6% Same window
Abnormal move -1.1% Stock minus SPY
Volume 1.4× Versus trailing sessions
Subsequent drift -1.1% Up to 20 sessions
SLFSPY benchmark

Ask FN2 about SLF FY2026 Q2

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

The latest call added stronger underlying EPS growth, continued Asia and U.S. momentum, new AI and health-solution initiatives, Bell integration, and further private-credit progress; management also emphasized Medicaid dental restructuring and fee pressure.

Guidance delta

Maintained; management's forward priorities remained focused on AI tools, health solutions, commercial dental expansion, Bell integration, and asset-management margin improvement.

Key takeaways

  • Underlying EPS growth and near-20% underlying ROE support the operating momentum case.
  • Asia sales, U.S. stop-loss, private-credit fundraising, and asset-management flows were highlighted as growth drivers.
  • Capital remained strong, but Medicaid dental restructuring, active-equity outflows, and pricing pressure remain watch items.

Management priorities

  • Roll out the agentic AI platform and AI-powered advisor concierge.
  • Expand health solutions and commercial dental while exiting unprofitable Medicaid contracts.
  • Integrate Bell and pursue asset-management growth and operating-margin improvement.

Follow SLF with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
SLF EPS earnings history estimate and actual scatter chart 10 reported fiscal quarters and 4 future estimate-only quarters. Q3 '23 estimate $1.15 Q3 '23 actual $1.19, beat Q4 '23 estimate $1.17 Q4 '23 actual $1.23, beat Q1 '24 estimate $1.20 Q1 '24 actual $1.11, miss Q2 '24 estimate $1.18 Q2 '24 actual $1.25, beat Q3 '24 estimate $1.25 Q3 '24 actual $1.29, beat Q2 '25 estimate $1.29 Q2 '25 actual $1.29, match Q3 '25 estimate $1.30 Q3 '25 actual $1.35, beat Q4 '25 estimate $1.35 Q4 '25 actual $1.41, beat Q1 '26 estimate $1.35 Q1 '26 actual $1.38, beat Q2 '26 estimate $1.39 Q2 '26 actual $1.46, beat Q3 '26 estimate $1.46 Q4 '26 estimate $1.49 Q1 '27 estimate $1.46 Q2 '27 estimate $1.51
Show less

Analyst Consensus ?

ConsensusHold15 ratings
Bullish426.7%
Neutral960.0%
Bearish213.3%

Analyst 52W Price Targets

$81.44Current
$50.93Low
$76.64Average
$92High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 22, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
Argus Research Buy BuyMaintainSep 3, 2026
RBC Capital Sector Perform Sector PerformMaintainAug 10, 2026
Credit Suisse Outperform OutperformMaintainAug 10, 2023
CFRA Hold HoldMaintainMay 12, 2020
CIBC Underperform NeutralDowngradeMar 14, 2019
Show 10 more rating actions

Named analyst price targets

Upside is calculated against the persisted current price $81.44. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
Argus ResearchAnalyst unavailable$88$79.46 +8.1%Sep 3, 2026
Argus ResearchKevin Heal$81$74.52 -0.5%Jun 10, 2026
Morgan StanleyAnalyst unavailable$89$60.41 +9.3%Oct 7, 2025
Capital One FinancialTom MacKinnon$92$60.9 +13.0%Nov 14, 2024
Stifel NicolausMike Rizvanovic$58.89$51.95 -27.7%Oct 4, 2021
See 1 more

Track every rating change on SLF the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

Sun Life Financial Inc. operates as a global financial institution, delivering a wide range of insurance, wealth management, and asset accumulation services to both individual and corporate clients worldwide. Its offerings encompass diverse life insurance products, including term and whole life policies, in addition to personal health, dental, critical illness, long-term care, and disability coverage. The company also engages in reinsurance activities, provides investment advisory and portfolio management services, and administers mutual and segregated funds. Furthermore, it offers trust and banking solutions, along with real estate brokerage, appraisal, and merchant banking services. Its distribution network is extensive, utilizing direct sales representatives, various general agents (both managing and independent), financial intermediaries, broker-dealers, banking institutions, pension and benefits consultants, and other external marketing organizations. Founded in 1871, the firm's headquarters are located in Toronto, Canada.

Financial Services peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the SLF recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-08-07T17:16:17.636512+00:00
  2. FN2 earnings calendar · 2026-09-11T01:23:15.000588+00:00
  3. Polygon adjusted daily market bars · 2026-09-22T00:40:47.747690+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-22T00:40:47.744963+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.